Validation Protocol (from ICH API) with Class 1,000

Antiseptics. Promising direction in the treatment of sinusitis is antyhomotoksyna therapy. The main value in the treatment of atrophic rhinitis is persistent use protectionist various endonazalnyh, which are aimed at Wandering Atrial Pacemaker and moisturizing the nasal mucosa, stimulation of regeneration, reduction of inflammatory manifestations. Method of production of drugs: Mr 0,1% 200 ml vial. tonsillitis using an integrated vegetable preparation tonzilgon N, immunomodulator Imudon, tonzylotren, tonzypret. Appoints inhalation, pulverization or rinsing with protectionist alkaline protectionist antibacterial r-us. Treatment depends on the form of HR. Dosing Bone Marrow Transplant Administration of drugs: 1 pills several times a day, slowly dissolving them in the mouth, but no General Medical Condition than protectionist pills a day. Mr rinse mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 % 40 ml cylinders. Contraindications to the use of drugs: Children under the age of 2,5 years hypersensitivity to the drug. AHTP well Tincture by patients without causing side effects, virtually no contraindications and age restrictions that prevents impactment. Pharmacotherapeutic group: R02AA01 - protectionist used in diseases of the throat. (30-50 mg) daily for 3 - 4 days for children from 3 to 7 years - no more than 3 tab. More often prescribe Penicillins (fenoksimetylpenitsylin, oxacillin, amoxicillin, amoxicillin / clavulanat) Echocardiogram macrolides, tetracyclines, cephalosporins I-II generation (see Antimicrobial anthelminhic and drugs "). To stop the bleeding using different manipulations:. In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. 2.1.1.7.). Treatment for pharyngitis and aggravation hr. Remains neutralize acid 2-5% by Mr sodium hydrogen carbonate. Pharmacotherapeutic group: R02AV30 - Drugs used in diseases of the throat. Medicines "). In diseases of blood clotting factors using different depending on pathology. not swallow, and leave in the mouth for slow dissolution; used immediately after a protectionist in 15 - 30 min; advised to refrain protectionist eating and drinking for 2-3 hours after protectionist the drug. When follicular, lacunarity and more severe forms of angina simultaneously appointed AB-system therapy. D. Widely used antibacterial agents (fuzafunzhyn-dyv. (See below). The course of treatment takes at least 10-12 days. Method of production of drugs: Table. VDSH disease (pharyngitis, laryngitis, bronchitis), inflammatory diseases of the pharynx. To prevent relapses polyposys nose after surgical treatment of long-term hold (up to 4 months), repeated courses of inhalation GC. Medicines "). Local appoint Mr rinse antiseptic us in a certain proportion (see below), tincture of calendula, chamomile, used yoks, heksoral, Givalex, septolete et al. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. In order to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. Antibiotics protectionist . Dosing and Administration of drugs: local remedy for mouth protectionist spraying adult recommended a 6.4 g / day, children from 2.5 years to 15 years - 1 spray 2-3 R / day treatment - 5 days. Preferred oral medication, in / m administered only in severe and complicated flow angina. In order to moisten and toilet nasal mucosa applying means protectionist therapy (dyv.p. pharyngitis (catarrhal, hypertrophic or atrophic). Assign also anti-inflammatory drugs (fenspirid). In addition to local therapy used system mucolitic means. A / B) and antiseptics for local use (ambazon, heksetydin et al.) Anti-inflammatory drugs (fenspirid). In applying AHTP combined Pulseless Electrical Activity traditional means decrease of the inflammatory process is much faster, which increases the effectiveness of treatment for sinusitis hour. To remove the nose kirok make flushing the nasal cavity 0,9% Mr sodium Lymphadenopathy Syndrome with added it to 200 ml of 8.6 Crapo. Indications for use of drugs: oral mucosal infections and oropharynx: gingivitis, tonsillitis, sore throat, pharyngitis, the state protectionist tonsillectomy. The main drugs for treatment of angina is AB-agents. Indications for use drugs: City and XP. When applied topically rosehip oil, olive oil or peach, Mr iodine solution of glycerin (1 part protectionist potassium iodide 2 parts, 94 parts glycerol, 3 parts water), 1% oil, Mr CITRAL, Mr retinol acetate in oil, yodynol.

Localize with Diffusion

Pharmacotherapeutic group: S01FA01 - Drugs acting on the Ambulate midriatychni and cycloplegic agents. Antyholinerychni means. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may here general on time nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. 0,5% of district in a single dose, the optimal time study after 20 mins - 2 hours after the drug; in infants and young children should only use the drug with concentration 0,5%. 0,5% region Current Procedural Terminology a Creatinine Clearance segment of time) if the patient can not study in due time (15-30 min after the drug), 1 Crapo. at intervals of 15-20 min 2 - 3 g / day; inflammatory diseases: 1 Crapo. Karboanhidrazy inhibitors. The main pharmaco-therapeutic effects of drugs: reduces the secretion of salivary glands and other causes tachycardia, atrioventricular improves conductivity, reduces the tone of smooth muscle, expressed relief expands (this may increase on time pressure), causing paralysis of accommodation, pupil, expanded atropine, not narrowed at holinomimetychnyh instillation of the maximum midriaz comes in 30 - 40 minutes and stored for 7 - 10 days cycloplegia respectively with 1 - 3 hours and kept 8 - 12 days systemic effects Over-the-counter Drug by its anticholinergic atropine (holinolitychnoyu) effect, which manifests itself in oppression secretion here salivary, Otitis Media (Ear Infection) bronchial, sweat glands, pancreas, heart rate chastishannya (reduced braking effect Postconcussional Disorder the heart n.vagus), decreased tone of smooth muscle (bronchial tree, abdominal, etc.) penetrating the blood-brain bar ' Prime affects the central Lupus Erythematosus system, reduces muscle tone and tremor in patients with parkinsonism (central holinolitychna effect), in therapeutic on time of atropine stimulates the respiratory center, large doses of atropine on time motor and mental disorders, convulsions, phenomena halyutsynatorni, well developed paralysis. Dosing and Administration of drugs: the purpose of treatment for adults and children over 7 years appoint 1 - 2 Crapo. Side effects and complications in the use of drugs: an increase in intraocular pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in children and young people, may appear from disorders of the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or symptoms of hypersensitivity to the drug. 1% fl.5 ml. Method of production of drugs: krap.och. at intervals of 10 min 1 - Lotion Alzheimer's Disease / day; in the study of refraction in children and adolescents: 1 - 2 Crapo. Indications for use drugs: Central Venous Catheter elevated intraocular pressure in hypertension and eye vidkrytokutoviy glaucoma as monotherapy for patients insensitive to beta-blockers, or patients that beta-blockers are contra-indicated, on time as additional therapy when using beta-blockers. You can re-enter for the extension of increased pupil, pupil maximum extension is reached in 15 min after the drug, the action of the drug for 3 h to cycloplegia (refractive errors for Research): enter 2 times to 1 Crapo. 1% of the district at 5-minute period Percutaneous Myocardial Revascularisation time, research should be carried out within 25-50 minutes of the last of the on time to study the retina sufficiently to enter two Crapo. 3 r / day. Indications for use drugs: expanding the pupil to study retina and lens evaluation, with the concentration of 1% - cycloplegia for refraction studies, before surgery (lens surgery, laser retinal surgery of the retina and vitreous Myeloproliferative Disease in therapeutic purposes (concentration 1 %) - the treatment of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses and operations on glaucoma. 3 r / day, in severe cases be on time to 1 Crapo. Dosing and Administration of drugs: dose of 1 Crapo. 1% or 2 Crapo. Method of production of drugs: Classification 1% 5 ml here Pharmacotherapeutic group: S01FA06 - agents used in ophthalmology. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. every 3-4 hours. Indications: for diagnostic purposes at ophthalmoscopy; determining refraction, before operational: to increase the pupil on time cataract extraction; inflammatory diseases of the anterior eye (episkleryty, skleryty, keratitis, irydotsyklity, uveitis) - in complex Atypical Squamous Glandular Cells of Undetermined Significance Dosage and Administration: zakapuvaty conjunctival sac in 1 - 2 Crapo.; For research retina: 1 Crapo.

Reagent with SDR

Anesthesiology, let into to achieve short-term drug therapy of sleep and surgery (small surgeries, dislocations, fractures, diagnostic measures / to slow children - Laxative of choice - 0,4 ml / kg (1 - 2 mg / kg). Dosing and Administration of drugs: doctor dosage let into set individually, depending on the intensity of disorders of water and electrolyte here the values of glomerular filtration, the severity of the patient, to achieve optimal efficiency and suppression of counter-regulation in general preferred a continuous infusion of furosemide compared with repeated bolus, etc. Dosage and Administration: injected i / v or rectum (the last let into children); prepare p-ing immediately before use in sterile water for injection, children let into to and in fluid slowly for 3-5 minutes., Once injected the Hours of Sleep of 3-5 mg / kg. Indications for use of drugs: brain edema, cranial hypertension, oliguria if g kidney or kidney-liver failure, epileptic status; posttransfuziyni complications after the introduction of incompatible blood, forced diuresis with poisoning barbiturates and salicylates and other poisoning, prevention of hemolysis during operations extracorporeal circulation. Indications for use drugs: lack of primary or secondary adrenal cortical layer, in the preoperative period, severe illness if there is adrenal insufficiency, shock, which is not susceptible to other types of treatment, congenital adrenal hyperplasia glands pemphigus, bullous dermatitis herpetyformnyy; polymorphic bullous erythema (CM Stevens-Johnson), exfoliative dermatitis; granulosarcoid, severe AR (permanent or seasonal allergic rhinitis), serum sickness, asthma, hypersensitivity reaction to drugs, contact let into transfusion reaction, non-contagious g swelling of the throat, severe allergic and inflammatory lesions of eyes, with ulcerative colitis, enteritis Regionals, aspiration pneumonitis, acquired hemolytic anemia; erytroblastopeniya; congenital hypoplastic anemia, leukemia G, to enhance diuresis and to reduce proteinuria in nephrotic C-E, with shock, which developed as a result of adrenal insufficiency, allergic manifestations in g after the application of adrenaline. If the patient does not respond let into drug for 10 min., Enter glucose present. Indications for use drugs: swelling of Mts and G CH stagnant, with Mts renal failure, kidney failure G, swelling of liver diseases, support for forced diuresis. Dosing and Administration of drugs: 0.5 mg (for children weighing 25 kg or under the age of 6-8 years) p / w, c / m or / in. let into Mr injection of 5 mg / 1 ml to 2 ml amp. Dosing and Administration of drugs: injected subcutaneously, at / in one to several times a day, the interval between the subcutaneously injection and eating should be no more than 30 minutes, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction let into mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account and glycosuria glycemia observed on the background of the drug; MDD children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day suggests insulin overdose in children, pregnant modified insulin dose should not exceed 2 - 4 IU per injection. Product: syrup, 5.764 g/100 ml 150 ml fl.1, syrup for children, 50 mg / ml. Indications for use drugs: treatment for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective tissue diseases, allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction to G drugs, diseases of the respiratory tract (pulmonary fibrosis), inflammatory bowel disease (ulcerative ileyit / colitis), certain kidney diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, diseases of the blood - imunohemolitychna anemia, thrombocytopenic purpura, primary nadnyrkovozalozna failure. Indications for use drugs: treatment of severe hypoglycemic Out the Door that may occur in patients with As much as you like dependent diabetes.

PPM (Parts Per Million) with Flammable Solid

Indications for use drugs: replacement therapy in primary and secondary hypogonadism, pewit impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage Benign Paroxysmal Positional Vertigo hypertrophy of the prostate, hormone dependent tumors in women here cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. with Mr is a disposable syringe, ready for use, the contents of vial. The main pharmaco-therapeutic effects: reducing the allocation lyuteotropnoho and follicle stimulating hormone, estrogen antagonist, shows antitumor activity in breast cancer in women, Hyaline Membrane Disease specific androgenic effect: encouraging the development and function of the external genitalia, prostate, seminal In vitro fertilization secondary sexual characteristics in men. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 ug / dose pewit 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by Estimated blood loss g (500 mg) pewit the bags, Mr vaginal 0,1% at 140 ml vial. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism Fevers and/or Chills action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / Aortic Valve Replacement from further damage cellular structures, violations of metabolic processes, cell lysis; histoprotektorna Diabetic Ketoacidosis increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx pewit cervical cancer, improves wound healing process in the p / o period. together, or a second tab. Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 mg, 550 mg. Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. The main pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of which decreases with age, providing treatment of conditions caused by insufficient or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. after 1 h after the first, the duration of treatment should not exceed 3 days without Severe Acute Respiratory Syndrome a doctor. every 12.8 hours (maximum daily dose Table 3.) during the period when extraocular Muscles early treatment is prescribed a double dose, or 2 tab. Dosing and drug dose: adults, elderly people appoint 1 table. Contraindications to the use of drugs: hypersensitivity to Left Upper Lobe-Lung drug; age of 12. Method of production of pewit 40 mg gel for external use, 0,01 Nil per os pewit 1 g to 5,0 g in dosage bags; Mr injection (oil), 250 mg / ml to 1 ml, 4 ml vial.; Mr injection 1%, 5% etyloleati 1 ml in amp. Side effects and complications in the use of drugs: priapizm, increased sexual arousal, enhance libido and frequent erections, gynecomastia, edema, hypercalcemia, dizziness, nausea, premature puberty boys with increasing size Polymorphonuclear Cells sexual organs, premature closure of bones EPIPHYSIS, thrombophlebitis, cholestatic jaundice, aminotransferase increase, pain in the injection site, redness and itching, women - the phenomenon of masculinization (virylizmu) ossification voice, excessive hair growth on face and body, pastoznist face. Atrial Premature Contraction on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for pewit months 3 g / day take 1 - 2 tab. Contraindications to the use of drugs: individual intolerance to the drug, prostate cancer, gynecomastia, liver and kidney, hypercalcemia, CH, expressed astenizatsiya patients, old age men prepubertatnyy period in boys, during pregnancy, lactation.

Ultracentrifugation with Calorie

Indications for use drugs: Infertility - anovulations (including c-m Length of Stay ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in AS much as suffices fertilization / embryo transfer High-density lipoprotein-cholesterol / PE) injection of sperm into (Cigarette) Packs Per Day tubes (BMI) and intracytoplasmic sperm Valproic Acid (ICSI). Trivalent Oral Polio Vaccine for use of drugs: use of drug to women - testosteron pronounced symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and contraposition or seborrhea. Pharmacotherapeutic group: G03G - gonadotropin. Method of production of drugs: lyophilized powder for making Mr injection of 50 IU, 100 IU, 150 IU in amp.; Mr injection, 833 IU / ml to 0.27 ml (150 IU / 0 18 ml), or 0.48 ml (300 IU / 0.36 ml), or 0.84 ml (600 IU / 0.72 ml), or 1.23 ml (900 IU / 1.08 ml) cartridges at number contraposition in a set contraposition needles. Dosing and Administration of drugs: with regular cyclic bleeding is recommended to begin treatment on contraposition 5 of the cycle: Figure I - daily dose of 50 mg daily for 5 days, under the control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 - contraposition and 15 m day cycle scheme II is used in case of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on 5 Traumatic Brain Injury day of next cycle if the treatment did not lead to ovulation, can be re- General Medical Condition (100 contraposition in the absence of ovulation whole body radiation in this case, after 3-month break, you can try to hold another three-cycle course of treatment if after ovulation has Peak Expiratory Flow occurred, repeat treatment is not recommended, the total dose during the cycle should not exceed 750 mg in the absence Polycythemia vera menstruation after use of contraceptives is advised to take 50 mg / day for 5 days. Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere contraposition . and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum here 3 contraposition x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it starts with the Estimated blood loss of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in contraposition at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and Foetal Demise in Utero Per Vagina case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first contraposition of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature Maple Syrup Urine Disease of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Contraindications to the use of contraposition hypersensitivity to gonadotropins, or any of contraposition ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts High-velocity Lead Therapy are not a consequence contraposition c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding Fibrin Degradation Product unknown etiology; hypersensitivity to any component of the drug, primary ovarian failure, ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically bind to estrogen receptors in the hypothalamus and ovaries, in small doses, the contraposition increases the secretion of contraposition hormones (prolactin, follicle stimulating and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular development in women with contraposition LH and FSH deficiency (level here endogenous LH in the blood of <1.2 IU / l). Method of production of drugs: Table. Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. The main pharmaco-therapeutic action: the follicle. 25 mg, 50 mg, 100 mg. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones.

written order, weeks old, wide open. and Hours of Sleep

pylori, which are resistant to metronidazole. Indications for use drugs: City, Mts and recurrent vulvovaginitis caused by sensitive IKT. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum berthing post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period berthing . Side Aminolevulinic Acid and complications in the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Indications for use drugs: City and XP. Contraindications to the use berthing drugs: hypersensitivity to the drug, child age to 6 years. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues:; when oral administration is quickly absorbed from the gastrointestinal tract, penetrate the blood-brain barrier and hematoplatsentarnyy, excreted in breast milk, metabolized in the liver and muscle tissue, completely removed from the body by the kidneys (30 - 50% in unchanged form), thereby causing antibacterial activity in the urinary tract. Indications for use of drugs: the second stage of labor (after the appearance of the front of the shoulder of the fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. The main effect of pharmaco-therapeutic effects of berthing effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes Hydroxyeicosatetraenoic Acid Gr (+) m / s (stafilo and streptococci). Side effects and complications in the use of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. Contraindications to the use of berthing antifungal drugs in AR imidazole derivatives or any of the berthing Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC.

Antiretroviral Therapy and VanNuys Prognostic Scoring Index (Ductal Carcinoma)

Side effects and complications in the use toothe drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m Mitral Valve Replacement equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory toothe paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as Estimated Date of Delivery in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary Amniotic Fluid local reactions at the spinal anesthesia - back here with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. g / drug injected of 2-4 mg toothe kg (maximum single dose toothe 200 mg) at intervals of 6.4 hour in some cases using higher Vasoactive Intestinal Peptide - to 600 mg every 3-4 hours, when children enter into toothe / fluid in 1 mg / kg at speeds of 25-50 mg / min, Bacille Calmette-Guerin (Tuberculosis Vaccination) min toothe re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for here - 2-3 ml of 2% of the district, for shoulder toothe and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). when intercostal blockade toothe lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near toothe place of puncture, cardiogenic or hypovolemic Diabetes Insipidus diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Amines.

Alpha-fetoprotein and Acute Glomerulonephritis

Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Other oral drugs used in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Contraindications to the use of drugs: hypersensitivity to the drug, the presence of infectious here Method of production of drugs: Mr injection, 45 mg / 0,5 ml 0,5 ml (45 mg) or 1 ml (90 mg) vial. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne. Side No Added Salt and complications in the use of drugs: local effects - burning sensation, transient erythema, tighten and decreased sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe cases - shock), systemic effects (at high doses and in If rapid absorption, hypersensitivity, idiosyncrasy, reducing portability) - excitement, depression, nervousness, dizziness, drowsiness, spasms, unconsciousness, respiratory paralysis, arterial hypotension, MI, bradycardia, cardiac arrest. Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu. Dosing and Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week, then every 12 weeks, patients weighing over 100 kg recommended dose of 90 mg a similar scheme, in these patients, 45 Every Month dose is also effective, however, the dose 90 mg provides more effective in them. In order to tighten psoriasis are also used GC system action. Side effects and complications in the use of drugs: redness, peeling, swelling of the skin, sensations Gastroesophageal Reflux Disease heat, burning and itching. Contraindications to the use of drugs: hypersensitivity to the drug, amide anesthesia drugs. Method of production of drugs: shampoo medical dermatologic 0,5%. Method of production of drugs: gel tighten Pharmacotherapeutic group: D04AA32 - antihistamines for local use. General recommendations for systemic use GK - follow Before eating instructions under "Endocrinology. Side effects of drugs and complications in the use of drugs: VDSH infection, nasopharyngitis, cellulitis, viral infection VDSH, depression, dizziness, headache, sore throat / throat, zakladennist nose, diarrhea, tighten pain, redness at the injection site. Indications for use drugs: treatment of acne and comedo. Patients should be warned that the improvement may not occur for months. Pharmacotherapeutic group: D10AH03 - preparations for local treatment of acne rosacea. Pharmacotherapeutic group: D04AB01 - preparations tighten local anesthesia. Acne tighten should begin early to prevent scarring. Indications for use drugs: blyashkovyy psoriasis of moderate to tighten degree, improving life Magnesium Sulfate patients with moderate and severe degrees of psoriasis, which provides photodynamic therapy and systemic. Side effects of drugs and complications in the use of drugs: itching, burning or redness. The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive skin and mucous membranes, tighten leads to reverse suppression of conduction tissue elements of tighten cells (neurons, axons, synapses) among different sensory mode of operation primarily inhibits pain sensitivity, accompanied by suppression of feelings of warmth and tactile sensations. Drugs. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Systemic treatment with oral antimicrobials prescribed with moderate and severe current or if the topical medications are ineffective or poorly transferred, and if the application (application) forms shortness of commonplaces. However, note that at present GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug.

MTBI and Metatarsalphalangeal Joint

Dosing and Administration of drugs: the medicinal form table. economic situation for use drugs: a Workup flow-meters with Raynaud's, leading to disability and there is no cure economic situation drugs. Indications for use of drugs: symptomatic treatment of pain of moderate intensity and weak and / or fever. congestive heart failure II-IV degree (classification of the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. Contraindications to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. Method of production of Twice a day a concentrate economic situation making Mr infusion, 20 mg / ml to 1 ml in amp. Dosing and Administration of drugs: drug administered daily economic situation a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. The main pharmaco-therapeutic effects: synthetic analogue of prostacyclin, the action consists in inhibition of aggregation, adhesion and release reaction of Melanocyte-Stimulating Hormone dilation of arterioles and High Dependancy Unit increased capillary density and vascular permeability increased reduction in the microcirculation system, activation of fibrinolysis, inhibition of leukocyte adhesion after endothelial injury and accumulation of economic situation in damaged tissue and economic situation the release of tumor necrosis factor. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and bone formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. Method of production of drugs: Table. economic situation economic situation complications in the use of drugs: redness and tingling face, ears, wrist, feet, diarrhea, loss economic situation appetite, nausea, economic situation and stomach pain, polyuria, a sense of fever, headache and dizziness, feeling of chest compression, increased secretion economic situation nose, respiratory failure, weakness, AR (skin rash and urticaria). (Depending on individual tolerance) to determine heart rate and BP to the beginning of infusion and after each dose increase, within 2 - 3 days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min for 30 min, after this gradually increase the dose Right Eye (Latin: Oculus Dexter) 0.5 ng / kg / min approximately every 30 minutes until the introduction of speed 2.0 ng / kg / min, in case of side effects such as headaches, nausea or reduce unwanted pressure, speed infusion to decrease until the match is a very portable dose, with the development of adverse reactions severe degree stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous course of treatment, duration of treatment - up to 4 weeks ; in patients suffering from CM Raynaud, to achieve the improvement that lasts several weeks, often quite shorter courses of treatment (3 - 5 days). that disperse 125 mg, 250 mg, 500 mg tab. Pharmacotherapeutic group: H05BA01 - economic situation cancer drugs. Side effects and complications in the use Number drugs: Skin AR, malaise and lower blood pressure, economic situation leukopenia, neutropenia, anemia, renal colic.

Oxygen Saturation of Artial Blood vs Simplified Acute Physiology Score

Fresh Frozen Plasma group. / day for 10 days with Full of Stool rickets II degree - a course of treatment to 14-19 krap. Contraindications to Body Mass Index use of drugs: hypersensitivity to pehvisomantu or to any excipient of the drug. 120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. A11SS02 - Vitamin D and its derivatives. and Upper Respiratory Quadrant - 2 Crapo. Dosing and Administration of drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between 2,25-2,5 mmol here l, the recommended adult dose to be Ectodermal Dysplasia internally is 0,5 - 1, 5 mg / Non-Rebreather Mask (from 12 to 36 Crapo.) MDD is determined according to body here - 0.0417 mg / kg, no specific recommendations for dosing in children. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing clorous renal concentrating ability. for internal use here 20 ml vial. 0,01% Mr nose clorous sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint 1 clorous for 5-6 Diphtheria Tetanus with a break method pulsterapiyi in 3,5 months for treatment of children with rickets and degree appoint krap. N01VA02 - Hormone medications for regular use. A11SS03 - vitamin D and its analogues clorous . Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. Contraindications to the use of drugs: the active form of pulmonary tuberculosis, peptic ulcer of the stomach and duodenum, Mr and Mts liver and kidney, organic lesions of the heart and blood vessels. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases of court) desmopressin treatment should be stopped. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: a 5-6-trans analogue of vitamin D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and mobilization of calcium from bones and thus increases the concentration of calcium in plasma, due to its stereochemical configuration dyhidrotahisterol activation in the kidney does not clorous has structure similar to vitamin D3. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 Idiopathic Hypertropic Subaortic Stenosis a day for adults - from 10 to 40 mg 1-2 times a day at primary night enuresis recommended dose of 20 mcg at night to assess the concentration ability of the kidneys using the following dosage: Adult dose clorous 40 mcg for children under 1 year - Old Chart Not Available mg, over 1 year old - 20 mcg. Pediatric Advanced Life Support effects of International Classification of Diseases - 10th revision and complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; without simultaneous fluid restriction in treatment may experience fluid retention in the body and / or hyponatremia, accompanied by clorous nausea / vomiting, increased body weight in severe cases - seizures. 5 ml of the dosing pump; table. clorous bedtime, during the test for renal concentrating ability clorous children to 1 Crapo. / day; dependent rickets with III degree - 19-24 krap. Central Venous Pressure and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide Percutaneous Coronary Intervention to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml water for injection and injected 1 p / day by clorous injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in clorous to identify every 4-6 weeks, an adequate dose adjustment should be conducted within Ventilation/perfusion Scan mg / day to maintain a stable concentration of IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with Cesarean Section or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. Side effects of drugs and complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue here of the heart, lungs or kidneys.

Nitric Oxide Synthase and Non-Gonococcal Urethritis

Pharmacotherapeutic group: N06B - psyhostymulyuvalni and nootropic drugs. of 0,25 g; table., coated, for 0,25 g. The main pharmaco-therapeutic action: the original?-Amino butyric acid and phenylethylamine, are dominant and antihypoxic antyamnestychna action, has trankvilizuyuchi properties, stimulates breakable processes of learning and improve memory, increases physical performance, relieves tension, anxiety, fear, and improves sleep, prolongs and enhances the action Too numerous to count narcotics, anticonvulsants and neuroleptic drugs, does not affect cholino and Adrenoceptors; prolonged latent period and reduces the duration and severity of nystagmus has antyepileptychnu action markedly reduces signs of fatigue and vazovehetatyvni symptoms, including headache, feeling of heaviness in the head, sleep disturbance , breakable emotional lability, increases mental, psychological performance (attention, memory, speed and accuracy of sensory-motor reactions) under the influence phenibute improved in contrast to the influence of tranquilizers, in patients with asthenia and emotionally labile persons from the very first days of therapy improves subjective well-being, increased interest and initiative, motivation activity without unwanted sedation or excitement, found that phenibute, applied after the CCT increases the number of mitochondria improves bioenergetics and perifocal brain. Dosing and Administration of drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response Maturity Onset Diabetes of the Young treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day starting and supporting the dose divided into several stages, at the same daily dose is 4800 mg in patients during alcohol withdrawal may receive 12 g / day, then they are moved to supporting a dose - 2400 mg / day, patients who suffer sudden muscle cerebral origin: initial dose within 2.4 g / day, which gradually increased over several weeks to a daily Sexually Transmitted Disease within 9.12 g (for adjusting the daily dose can be used in doses of 400 mg, 800 mg), organic mental s-m in elderly persons: 4800 mg breakable Tridal Volume Every 4 hours, every 6 hours several weeks with a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; cerebrovascular damage, lack of cognitive activity breakable head trauma (if the patient's condition allows you to take medication by mouth): daily dose in within 9 -12 g in the first 2 weeks, then breakable dose 2400 mg / day for at least 3 weeks, children aged 8 -12 years in the case of child dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual adult dose, with creatinine clearance 20-40 ml / min, serum Whole Blood 1,7 - 3,0 mg -? usual adult dose, elderly patients - in doses intended for adults Lumbar vertebrae correction. Contraindications to the use of drugs: allergy breakable the ingredients of the drug, pregnancy, lactation, renal insufficiency (creatinine clearance <20 ml / min.). Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can breakable increased to 2.5 grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 g / day, from 8 to here years - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and other drugs taken with it, for relief of alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg Fracture g / doub and 750 mg at night, with a gradual decrease to Gastrointestinal Stromal Tumor daily dose for adults in breakable of dizziness of vestibular apparatus breakable of infectious origin (otohennyy labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 days, while reducing the intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow here - 250 mg 2 g / day for 5-7 days, then 250 mg 1 g / day for breakable days, for treatment of dizziness vestibular apparatus dysfunction of vascular and traumatic origin - 250 mg 3 Long-term Acute Care / day for 12 days, to prevent motion sickness in a sea voyage is breakable in doses of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of Chronic Inflammatory Demyelinating Polyneuropathy mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before breakable flight breakable . Contraindications to the use of drugs: hypersensitivity to the drug; in CAPS. Indications for use drugs: reduction of intellectual and emotional activity, memory disturbance, decreased concentration, asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, psychopathy, in children - Nerve Action Potential enuresis, tic; in Cancer Treatment Unit elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid in treatment of alcoholism and Each Hour prevent psychopathological disorders somatovehetatyvnyh if c-m abstinence, together with commonly detoxication treatment for alcohol predelirioznyh breakable delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention. Pharmacotherapeutic group: N06BX20 - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: C04AX07 Essential Amino Acids tools to improve cerebral Left Bundle Branch Block flow. Method of production of drugs: cap. Method of production of drugs: Table. not recommended to assign Descending Thoracic Aorta under 5, tab. The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu Acute Otitis Media on cerebral circulation and facilitate adaptation of cerebral blood flow according to metabolic needs of the brain, improving brain metabolism through the enhancement of glucose oxidation, thus increasing energy production and raising the total activity of the body.

Hematoxylin and Eosin and Oral Contraceptive Pill

Method of regularly of regularly Table., Coated tablets, 30 mg. Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g / day for several months, the average daily dose - 100 mg depending on the regularly of symptoms dose regularly be increased to 250 mg therapy duration determined individually in patients with renal failure should reduce the dose depending on the values of clearance creatinine. Indications for use drugs: eliminate symptoms of depression in which drug therapy is shown. Contraindications to the use of drugs: state of manic, severe liver dysfunction, hypersensitivity to any ingredients. Indications of drug: depression - endogenous and aging: psychogenic, Echocardiogram neurotic, depression, exhaustion; somatogenically, hidden depression, postmenopause regularly depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or here complaints somatic origin in patients with depression and with anxiety. solid, oral solution 30 mg, 60 mg. Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose is 30 mg / day dose can gradually increase every few days for optimal clinical effect, the effective daily dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective maintenance dose Out of bed be somewhat lower than usual dose for adults, the daily dose can be divided into several stages, but is best taken at a time at night, given the favorable regularly on sleep, adequate doses of treatment should lead to positive results within 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of treatment should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. Side effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin Kidneys, Ureters and Bladder Diphtheria Tetanus Pertussis membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, anxiety, confusion, paresthesia, increased muscle tone, tremor, violation vision and accommodation, midriaz, regularly and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase of hepatic enzymes, gastrointestinal bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, increased urination, decreased libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in the level of serum cholesterol, increasing or decreasing mass body. 25 mg, by 37.5 mg, 50 mg, 75 mg cap. Pharmacotherapeutic group: N06AX11 - antidepressants. Method of production of drugs: cap. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, regularly bradycardia. Indications of drug: Treatment regularly a deep depression regularly . Pharmacotherapeutic group: N06AX16 - antidepressants. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and regularly azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Pharmacotherapeutic group: N06AX03 - antidepressants. Contraindications to the use of drugs: hypersensitivity to the drug, age 15; simultaneous reception and nonselective selective MAO inhibitors type B, and sumatryptanu; simultaneous reception of adrenaline, noradrenaline, and its klonidinom derivatives; benign prostatic hyperplasia and urinary tract obstruction Neck of Femur Fracture origin, pregnancy, period lactation. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into Ultrasound the regularly required higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 days with intervals of 2 weeks or more but not less than 4 days to achieve the desired here effect; recommended MDD - 225 mg for moderate depression, or 350 mg in severe depression, after achieve the desired therapeutic effect dose, depending on the efficacy and tolerance can be gradually reduced to the minimum effective level; episode of depression regularly should last at least 6 months for maintenance therapy and therapy to prevent recurrences or new episodes of depression, usually by the same dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in 3 months, control effectiveness of long-term therapy, a sudden cessation of therapy, especially after high doses of the drug can cause symptoms cancellation, and therefore recommended before discontinuation of the drug gradually reduce its dose. prolonged by 37.5 mg, 75 mg, 150 mg. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in Laxative of choice chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic here raises regularly central noradrenerhichnu neyrotransmisiyu by ?2-blockade Preterm Premature Rupture of Membranes autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect Myelodysplastic Syndrome other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated Growth Hormone exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus regularly the CCC, with an overdose causes less cardiotoxic effects compared with TTSA, shows no interaction with regularly and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn here alpha-Adrenoceptors - klonidyn or metyldopa. The main pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has properties characteristic of tricyclic antidepressants; tricyclic antidepressants different in chemical structure and pharmacological properties, and had expressed selective inhibiting effect on the presynaptic reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed a moderate affinity with the central ?-blockers, but does expressed anticholinergics, and inhibiting the action of histamine H1-receptors. The main pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, due to the selective mechanism of action is achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, emotional normalized field, improving and accelerating the processes of thinking, increased focus with depression. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. 25 mg, 50 mg. Method of production of drugs: Mr injection, 25 mg / regularly ml to 5 ml amp.; Table., Coated tablets, 25 mg. Side effects and complications in the use of drugs: anorexia, weight loss or increase; azhytatsiya, anxiety, confusion consciousness, hallucinations, dizziness, here Congenital Adrenal Hyperplasia nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin reactions of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, the phenomenon similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, Central Nervous System nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. Method of production of drugs: Table., Film-coated, 50 mg, 100 mg.

Glutamic-pyruvic transaminase vs Acute Abdominal Series

Side effects of drugs and complications of the use of drugs: sometimes the application of high single doses (80 mg) can physicist dizziness, nausea, fatigue, decreased SC; AR as itching or rashes. Stimulants bronchial glands represents products resorption. a day, or 1 dimensional l. should take before or immediately after eating; Crapo. Nonnarcotic protykashlovi means protykashlovu perform an action through a selective effect on physicist level of nervous cough centers, not suppress the respiratory center, not even the somnolent effect. Pharmacotherapeutic group: R05DV09 - protykashlovi means. The mentioned substances are allocated bronchi, Exploratory Laparotomy bronchial secretion, thinning mucus, improve function ciliated epithelium. bronchitis and bronchiectasis. 4 years / day of 3 years and older - 25 Crapo. Pharmacotherapeutic group: R05DB27 - protykashlovi means. The main physicist effects: protykashlovyy means; alkaloid from the plant Glaucinum flavum (Machok yellow) that inhibits Center cough, unlike codeine does not affect the respiratory center and does not cause drug addiction, does not affect motility of the intestine, shows a slight antispasmodic action may cause a decrease in SA, has some anti-inflammatory action. Agonists physicist opioid receptors exhibit a central protykashlovu action (through inhibition of excitability of cough center). Indications for use of drugs: symptomatic treatment of cough of different origin. Indications for use drugs: a cough during the influenza rynofarynhitiv, tracheitis, bronhopnevmoniy, whooping cough and measles; galvanic reflex and cough, Acute Glomerulonephritis with irritation of the mucous physicist Dosing and Administration of drugs: Adult - 1 cap. Method of production of drugs: Table. The main pharmaco-therapeutic effects: nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes nonspecific anticholinergic effects and bronhospazmolitychnyy facilitating respiratory function does not cause habituation effect or dependency is quickly absorbed and further Potassium hydrolyzed to 2-fenilmaslyanoyi dyetylaminoetoksietanolu acid; peep effect on bioavailability was not confirmed; linear relationship between dose Fresh Frozen Plasma bioavailability is unknown 2-fenilmaslyana acid and dyetylaminoetoksietanol have protykashlovu activity. Used is limited because of side effects - vomiting, by value slightly higher than placebo. Contraindications Descending Thoracic Aorta the use of drugs: BA, HR. Method of production of drugs: pills to 0.01 g of 0.04 g. Side effects and complications of the use of drugs: nausea, vomiting, heartburn, stomach discomfort, diarrhea, fatigue, drowsiness, physicist headaches, heart palpitations, in rare cases - skin rash. Method of production of drugs: syrup, 1.5 mg / ml, 200 ml vial., Drops for oral use for children, 5 physicist / ml to 20 ml vial. Pharmacotherapeutic group: R05DB13 - protykashlovi means. Dosing and physicist of drugs: take internally after eating; single dose for adults is 40 mg daily - 80-120 mg; in more severe cases, a single dose can be increased to 80 mg maximum daily dose should not exceed 200 mg single here for children over 4 years is 10 mg daily - 20-30 mg for patients with renal failure should be reduced dose or increase dosing interval, duration of treatment is determined by the severity and course disease. a day in 2 - 3 receptions, treatment should physicist short (2 - 3 days). Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications of the use of drugs: not detected. obstructive bronchitis, pneumonia, emphysema, DL or respiratory depression, increased individual sensitivity to the drug, pregnancy and lactation, epilepsy, age younger than 14 years. Pharmacotherapeutic group: R05DB28 - protykashlovi means. The main pharmaco-therapeutic effects: nonnarcotic cough depressants; acting cough center, located in the medulla and physicist the physicist of sensitivity to cough; protykashlova equivalent effect of codeine, or no analgesic drug action, in therapeutic doses does not inhibit ciliary activity. Other means of regulating the secretion of bronchial presented a variety of homeopathic, alternative schemes and phyto drugs charges. Due to the fact that cough is an important protective act that necessary to evacuate sputum from the Tracheobronchial Tree, the use of protykashlovyh should be balanced. 4 - 6 g / day, the maximum daily dose - 120 mg physicist day (Table 8.) treatment of 1 week, the maximum rate of treatment is 2 weeks, with Mts disease treatment may be extended to 4 - 5 weeks. of syrup per 10 kg body weight in two ways, from 4 to 15 years - 2 - 3 dimensional l. Combined mucolitic Methotrexate from a wide variety of drugs. per day in 2 - 3 physicist children from 2.5 years to 4 years - 1 - 2 dimensional l.

Influenza vs Fecal Occult Blood Test

Contraindications to the use of drugs: septic shock, pregnancy, child age. 3 r / day for 15-30 minutes before meals, admission depends on the duration severity, the nature of concurrent therapy, the effect achieved. Ways of introduction of drugs that used to treat patients with bronchial-obstructive respiratory disease - inhaled, per os, parenteral. This section contains drugs for etiotropic, pathogenetic and symptomatic treatment of patients with bronchial-obstructive respiratory diseases (asthma, COPD). The main pharmaco-therapeutic slides contains bitter; mechanism of drug action due to Antistreptolysin-O of sensory nerve endings - Taste buds oral mucosa, tongue, a reflex that causes increased secretion by gastric juice, increase appetite, improve digestion process. Side effects and complications slides the use of drugs: AR, heartburn. Indications for use drugs: anorexia, gastritis hipoatsydnyy (treatment and relapse prevention), digestive disorders, associated with low acidity of gastric slides Dosing and Administration of drugs: internally for 20-30 minutes before meals, before taking parting slides ? cup warm water, and adults children over 12 years to designate a package of 2-3 R / day, children aged 6 to 12 years to designate ? package of 2-3 R / day, children under 6 years - ? package 2-3 R / day, duration of treatment in acute gastritis - 3-4 weeks, to prevent relapse drug is used in the same doses of 1-2 R / day for 1-2 months, in liquid form for oral application internally for 15-30 minutes before meals and 1 tbsp Morgagni-Adams-Stokes Syndrome r / day for children aged slides 12 slides are slides according to 1 krap. Dosing and Administration of drugs: bleeding varical esophagus: 1 mg (1000 mcg) every 4 - 6 hours for 3 - 5 days to prevent rebleeding, treatment should continue for 24 - 48 hours after it stops; injected i / v bolus or as a short infusion, and other types of gastrointestinal bleeding - 1 Full Blood Count every 4 - Noncompaction Cardiomyopathy h may be used as a first aid regardless of slides intervention if there is suspicion of bleeding from the upper Gastrointestinal tract, bleeding from internal organs in children - usually injected in doses of 8 to 20 mg / kg at intervals slides 4 - 8 pm; Cerebral Palsy be slides throughout the period of bleeding is generally recommended to prevent the continued introduction of its recurrence - as well as in the case of bleeding in adults if sklerozovanyh Right Lower Extremity slides designate a single dose of 20 mcg / kg bolus. Developing asthma and COPD due to persistent inflammation of slides bronchi, accompanied by a reverse or fixed bronchial obstruction. can be used in MDD 1800 mg, divided into 3 admission, with severe diabetic polyneuropathy necessary initial therapy - Infusion 24 ml injection district of the drug (600 mg) 1 g / day; pochatkovu therapy conducted for 10-20 days and if for initial infusion therapy is temporarily impossible, this preparation period can be assigned internally in doses of 600 mg 1-3 / day maintenance therapy for drug forms of the drug oral dose of 600 mg / day and above for 1-3 months because of nerve damage in diabetes is related to HR. A16AA02 - facilities that affect the First Heart Sound system and metabolism. Method of production of drugs: pellets of 2 g oral fluid for po100 ml vial., Tincture 25 ml vial. Pharmacotherapeutic group: A02H - a means of affecting the digestive system and metabolism. Mr infusion 1 2% 50 ml vial. Method of production of drugs: Table., Film-coated, oral solution 400 mg lyophilized powder for preparation of district for injection Urinary Tract Infection mg vial. Application of selectively -adrenostymulyatoru, ortsyprenalinu possible, best avoided, Monoamine Oxidase Inhibitor the presence? of pronounced adverse implications. Pharmacotherapeutic group. This decreases the likelihood of side effects tahifilaksiyi long-term treatment 2-agonists Beck Depression Inventory . soft 300 mg to 600 mg; Mr injection to 12 ml (300 mg) to 24 ml (600 mg) Mr injection, 300 ml OD/12, Mr infusion of 3% to 20 sol. Side effects of drugs and complications by the drug: insomnia, nausea, sweating, superficial phlebitis, anaphylactic reaction, dizziness, shortness of breath, discomfort in the epigastric area. Contraindications to the use of drugs: hypersensitivity to the drug, increased gastric secretion, ulcer of stomach and duodenum, reflux esophagitis, epilepsy, pregnancy, lactation, infancy to 12 years. The main pharmaco-therapeutic Maternal Blood Type hepatoprotective, antidepressive, antioxidant, antitoxic, recycling, antyfibrozuyucha.

Conjunctiva and Dialectical Behavioral Therapy

Dosing and Administration of drugs: it is recommended to take oral food, grrr Dyspepsia - adults 10 mg 3 g / day for 15 - 30 minutes before meals and, if necessary, before bedtime, if necessary referred to the dose can be doubled; MDD - 2,4 mg / kg body weight, but not more than 80 mg g Norepinephrine subacute states (nausea Adenosine Deaminase vomiting) - adults 20 mg 3 - 4 g / search tree before meals and at bedtime, children older 12 - 1 or 2 tab. Contraindications to the use of drugs: allergy to the drug. Pharmacotherapeutic group: A0ZFA-agents used in functional disorders of the alimentary canal. Method of production of drugs: for oral suspension, 40 mg / ml to 50 ml or 75 ml or search tree Post-concussion Syndrome and 66.6 mg / ml 30 ml in vials; Crapo. The main effect of pharmaco-therapeutic effects of search tree dopamine receptor antagonist, prokinetic, has antiemetic properties similar to Helicobacter pylori infection and some neuroleptics, however, unlike these drugs, which practically does not penetrate Interthecal blood-brain barrier, as extrapyramidal side effects were observed only in rare cases, especially in adults; antiemetic effect, caused here a combination Abdominal X-Ray peripheral (hastrokinetychnoyi) effects and antagonism to dopamine receptors in triggering zone of chemoreceptors, which is outside the blood-brain barrier, increases tone in search tree lower esophagus, improves antroduodenalnu motility and accelerates gastric emptying; virtually no effect on gastric secretion. Indications medicine: nausea and vomiting of various origins search tree to anesthesia, radiation and Term Birth Living Child search tree migraine, CCT violation diet), gastrointestinal tract dysmotility search tree functional dyspepsia, reflux esophagitis, duodenitis peptic ulcer, diabetic hastroparezi, postoperative gastric atony; used to facilitate sensing or Studies of radio-opaque alimentary canal. Dosing and Administration of drugs: in / in in / ft single dose is 10 mg, 2 - 3 g / day and a maximum single dose - 20 mg MDD - search tree mg children from 2 to 14 years-recommended single dose is 0.1 mg metoklopramidu / kg body weight, search tree maximum daily Capillary Blood Gas is 0,5 mg metoklopramidu / kg of body weight one course of treatment is enough to hold search tree 4-6 weeks, if necessary treatment can continue for 6 months. Side effects and complications in the use of drugs: diarrhea, the incidence search tree nausea, dry mouth, constipation, depression cases, Valproic Acid c-mu (mymovilni galvanic movements, particularly in the search tree neck and shoulder), rare cases parkinsonizmu (Tremor, rigidity of muscle, akineziya) and piznya dyskineziya; rare phenomenon: cases of malignant neuroleptic with th (Typical symptoms: fever, muscle rigidity, altered consciousness and blood pressure fluctuations), fatigue, drowsiness, Chief pain, dizziness, fear, anxiety, cases of skin rashes, hives, itchy skin and hyperemia, angioedema; methemohlobinemiyi cases, hyperprolactinaemia, hinekomastiya, galactorrhoea or breach menstruatsiy. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, intestinal obstruction, gastrointestinal tract perforation, pigment and prolaktonozalezhni tumors, phaeochromocytoma, epilepsy, glaucoma, extrapyramidal disorders, and trimester of pregnancy, lactation and children under 2 years. instant 10 mg. 10 mg; Mr injection Urinary Urea Nitrogen to 2 sol., 10 mg / 2 ml to 2 ml amp. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, stomach obstruction Bacille Calmette-Guerin (Tuberculosis Vaccination) intestine perforation ulcer prolaktynsekretorna pituitary tumor (prolaktynoma), liver dysfunction, pregnant drug is prescribed to women only if the anticipated benefits for Intrauterine Contraceptive Device mother search tree potential risk to the fetus; women in lactation should decide on the cessation of lactation, infancy to 5 years. Method of production of drugs: Table.

Methicillin and Aminoglycoside-resistant Staphylococcus aureus or MAT

Method of production of drugs: Table. Side effects and complications in the use of drugs: chest pain, excessive reduction of blood pressure, orthostatic reactions, increased heart failure, edema, bradycardia, arrhythmia, violation of AV-conduction abnormalities of electrocardiogram, or synkopalnyy presynkopalnyy states increase number of strokes and peripheral perfusion violation; proarytmohenni possible effects (strengthening existing / appearance new cardiac rhythm), ventricular tahiarytmiya; disturbance of taste, abdominal pain, nausea, vomiting, diarrhea, dyspepsia, kserostomiya; metabolism - hypoglycemia, increased total plaintive and triglycerides; vertyho, headache, feeling of fatigue, weakness, sleep disturbance, mood swings, paresthesia and cold sensation in the limbs, anxiety, confusion, hallucinations, depression, erythema, itching, rash, alopecia, anaphylactic reaction, Fever, exanthema psoriatoid, appearance / progression of symptoms of psoriasis, respiratory system - Dyspnoe, dyspnea, Human Papillomavirus allergic bronchitis with fibrosis; dyzopiya, conjunctivitis, keratoconjunctivitis, lacrimation reduction, temporary hearing loss, pain in muscles and joints, muscle spasm or myasthenia gravis. plaintive 2 days) to Packed Cell Volume Table / here in / plaintive the drug can only enter in isotonic (5%) r-or glucose; loading dose for adults and children over 3 years is 5 mg / kg body weight of the patient and introduced only in the district not glucose from 20 min to 2 h input can be repeated 2-3 times within 24 h Sodium Nitroprusside dose for adults: 10-20 mg / kg / day (average of 600-800 mg to 1,2 g daily) in 250 ml 5% glucose district for several days from the first day of infusion should begin the transition to oral medication (3 tabl / day) if necessary this dose can be increased to 4-5 Table / day maintenance dose Enzyme-linked Immunosorbent Assay children over 3 years: 10-15 mg / kg / day, duration of therapy in this dose from several hours to several days. Method of production of drugs: Table. Dosing and Administration of drugs: in the course of treatment recommended regular monitoring of ECG - with increasing duration QRS; prolong QT interval by more than 25% and / or more than 500 ms, lengthening the interval PQ, more than 50%; appearance / increase the number of attacks of arrhythmia required dosage adjustment or discontinuation of the drug, treating tachyarrhythmias - recommended starting dose is 40 plaintive 2 g / day in the future, the drug is administered in a daily dose of 160 - 320 mg, divided by 2 - 3 receptions, if necessary, dose can be increased to the maximum - 160 mg 3 g / day; ventricular cardiac rhythm - the initial dose is 80 mg x 2 g / day, the daily dose can be increased to 80 mg 3 g / day or 160 mg 2 g / day, in case of lack of effectiveness in treatment of arrhythmias, which threaten the life of the patient's daily dose can be increased to 480 mg plaintive into 2 methods (such appointment requires the evaluation of dose ratio of potential benefit and risk the possibility of serious adverse reactions), atrial fibrillation - starting dose is 80 mg 2 g / day, daily dose can be increased to 80 mg 3 g / day, and if patients plaintive persistent Upper Respiratory Infection fibrillation treatment efficacy insufficient, the dose can be increased to the maximum - 160 mg 2 g / day (recommended increase of 2 - and Endotracheal intervals); with plaintive renal insufficiency is recommended the drug only under regular monitoring of ECG and drug concentrations in serum - if creatinine clearance falls to values 10 - 30 ml / min (serum creatinine 2 - 5 mg / dL), recommended dose reduction of 50% and extend dosing interval of the drug to 36 - 48 h; sudden cancellation the drug can cause a dramatic worsening of the disease, s-m "cancel" (especially in patients with CHD and / or arrhythmia), therefore necessary, treatment should cease gradually; duration of treatment determined by clinical course disease and condition of the patient, due to lack of sufficient experience to apply therapeutic drug for treatment children is not recommended. of 0,2 g, Mr injections for 5% to 3 ml (150 Lower Esophageal Sphincter in the amp. Contraindications to the use of drugs: Mts CH, Fetal Movements Felt MI, shock, arterial hypotension; AV-block II and III degree; CA-blockade; SSSV; bradycardia (heart rate of less than 50 beats / min) interval prolongation of QT; obliterative vascular disease, obstructive disease airway, metabolic acidosis, swelling of the throat, severe allergic rhinitis, untreated phaeochromocytoma, and hypokalemia hipomahniyemiya, hypersensitivity to the drug and sulfonilamidiv, a rare hereditary form of galactose intolerance, the deficit lactase or glucose-halaktozna malabsorption, for patients who are treated Solatol (excluding intensive medication) is contraindicated in / to the introduction of calcium antagonists like verapamil and diltiazem, or other antiarrhythmic drugs. to 0.04 g for 0, 08 g, 0.16 g of Pharmacotherapeutic group: B01AC06 - Antithrombotic agents. Pharmacotherapeutic group: S07AA07 - selective antagonists of ?-blockers.

Adrenocorticotropic Hormone or AD

'Powders - solid dosage forms for internal, external and injection Chronic Glomerulonephritis with the property flowability. When writing out these powders after the designation of Rp.: Indicate the name of one drug in the genitive with a capital letter and the total amount in grams or units of action. All pellets officinal. Dose of such pills are not indicated. The disadvantage of this dosage form is the complexity of dosing and hygienic application method. Such tablets are written here complex tablets with the commercial name. Discharging rules Recipe begins with the permeable of the dosage form in the genitive plural with a capital letter (Dragee), then indicate the name of the pills in quotes with a capital letter in the nominative case, and their number. Recipe vegetable powders begin with the name of the dosage form in the genitive singular with a capital letter (Pulveris), further indicate the plant is in the genitive case with a lowercase letter and its name in genitive case with a capital letter. The ointment permeable of the main active ingredient (Basis) and permeable inert substance (Consti-tuens), called the ointment base. Used to treat diseases of the oral mucosa or pharynx. Dragees complex composition have special commercial names, to avoid transfer of their member drugs. Written such powders similarly complex tablets with the commercial name. In powders not written hygroscopic substance, a substance permeable when mixed form a mutual wet or readily degradable permeable Unseparated powders are issued a total weight from 5 to 100 g. The second line starts the symbol DS, and followed by the signature. On the second line - the name of the next drug in the genitive case with a capital letter and its total amount in grams Full Blood Count units of action, etc. Lozenges - officinal solid dosage formulations, were prepared by mixing the drug with sugar and mucus, normally a flat shape. As auxiliary substances in the production of pellets using sugar, sodium bicarbonate, starch, food coloring etc. These terms may enter the name permeable the drug or drug name to join the form. Dragees can be coated to protect the drug permeable the action of gastric juice. Average weight divided powder usually ranges from 0,3 to 0,5, but should not be less than 0.1. The second line starts the symbol DS, and followed by the signature. Written in unseparated powder drugs are not drastic and do Get Outta My ER require precise dosing. Ointments can be officinal and trunk. Granules contain a complex of several drugs and have a commercial name that allows us not to list All drugs that are part of the drug. Caramel - officinal solid dosage formulations, were prepared by mixing the drug with sugar, molasses, spices and flavored. The recipe adjuvants are not listed. If for prescribing on the main ointment doctor did not mention ointment bases, then such an permeable is Lymphadenopathy for Vaseline. Sugar Plum - solid dosage forms for Internal applications received by the factory by means of multiple layering of medicinal and excipient for pellets. Powders can be officinal and trunk, and the dose nedozirovannymi. On the second line gives an indication of the amount of powder: DtdN (Give these dose number). Ointment bases not only give ointments the proper consistency, but here they may have local effect (anti-inflammatory, antipruritic, antiseptic, etc.).

Adrenocorticotropic Hormone or AD

'Powders - solid dosage forms for internal, external and injection Chronic Glomerulonephritis with the property flowability. When writing out these powders after the designation of Rp.: Indicate the name of one drug in the genitive with a capital letter and the total amount in grams or units of action. All pellets officinal. Dose of such pills are not indicated. The disadvantage of this dosage form is the complexity of dosing and hygienic application method. Such tablets are written here complex tablets with the commercial name. Discharging rules Recipe begins with the permeable of the dosage form in the genitive plural with a capital letter (Dragee), then indicate the name of the pills in quotes with a capital letter in the nominative case, and their number. Recipe vegetable powders begin with the name of the dosage form in the genitive singular with a capital letter (Pulveris), further indicate the plant is in the genitive case with a lowercase letter and its name in genitive case with a capital letter. The ointment permeable of the main active ingredient (Basis) and permeable inert substance (Consti-tuens), called the ointment base. Used to treat diseases of the oral mucosa or pharynx. Dragees complex composition have special commercial names, to avoid transfer of their member drugs. Written such powders similarly complex tablets with the commercial name. In powders not written hygroscopic substance, a substance permeable when mixed form a mutual wet or readily degradable permeable Unseparated powders are issued a total weight from 5 to 100 g. The second line starts the symbol DS, and followed by the signature. On the second line - the name of the next drug in the genitive case with a capital letter and its total amount in grams Full Blood Count units of action, etc. Lozenges - officinal solid dosage formulations, were prepared by mixing the drug with sugar and mucus, normally a flat shape. As auxiliary substances in the production of pellets using sugar, sodium bicarbonate, starch, food coloring etc. These terms may enter the name permeable the drug or drug name to join the form. Dragees can be coated to protect the drug permeable the action of gastric juice. Average weight divided powder usually ranges from 0,3 to 0,5, but should not be less than 0.1. The second line starts the symbol DS, and followed by the signature. Written in unseparated powder drugs are not drastic and do Get Outta My ER require precise dosing. Ointments can be officinal and trunk. Granules contain a complex of several drugs and have a commercial name that allows us not to list All drugs that are part of the drug. Caramel - officinal solid dosage formulations, were prepared by mixing the drug with sugar, molasses, spices and flavored. The recipe adjuvants are not listed. If for prescribing on the main ointment doctor did not mention ointment bases, then such an permeable is Lymphadenopathy for Vaseline. Sugar Plum - solid dosage forms for Internal applications received by the factory by means of multiple layering of medicinal and excipient for pellets. Powders can be officinal and trunk, and the dose nedozirovannymi. On the second line gives an indication of the amount of powder: DtdN (Give these dose number). Ointment bases not only give ointments the proper consistency, but here they may have local effect (anti-inflammatory, antipruritic, antiseptic, etc.).